Loading...
Chemical structure of SB202190 (FHPI)

GC13968

SB202190 (FHPI)

Also known as 4-[4-(4-fluorophenyl)-5-pyridin-4-yl-1H-imidazol-2-yl]phenol

SB 202190 is a selective p38 MAP kinase inhibitor with IC50s of 50 nM and 100 nM for p38α and p38β2, respectively

ChemicalCAS152121-30-7MW331.34FormulaC20H14N3OF
CAS number
152121-30-7
Molecular weight
331.34
Formula
C20H14N3OF
Solubility
≥ 57 mg/mL in DMSO, ≥ 22·47 mg/mL in EtOH
InChIKey
QHKYPYXTTXKZST-UHFFFAOYSA-N
Catalogue number
GC13968
Brand
GLPBIO
Computed properties PubChem CID 5169 · XLogP 3.7 · TPSA 61.8 Ų · H-bond donors 2
XLogP
3.7
TPSA
61.8 Ų
H-bond donors
2
H-bond acceptors
4
Rotatable bonds
3
Heavy atoms
25

SMILES C1=CC(=CC=C1C2=NC(=C(N2)C3=CC=NC=C3)C4=CC=C(C=C4)F)O

Computed descriptors from PubChem (CID 5169), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.